These subgroups affect both the likelihood and timing of cancer recurrence: triple-negative/basal-like, HER2-positive, and luminal B BC are at greater risk of early recurrence relative to luminal A cancers, which have a longer latency period of possible recurrence [5]. This evidence concerns the gene ERBB2 and breast cancer.